Immune-mediated cholangitis: is it always nivolumab’s fault?

被引：0
|
作者：
Francesco Gelsomino
Giovanni Vitale
Andrea Ardizzoni
机构：
[1] Policlinico S. Orsola-Malpighi,Medical Oncology Unit
[2] University of Bologna,undefined
来源：
Cancer Immunology, Immunotherapy | 2018年 / 67卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1325 / 1327
页数：2
相关论文
共 50 条
  • [1] Immune-mediated cholangitis: is it always nivolumab's fault?
    Gelsomino, Francesco
    Vitale, Giovanni
    Ardizzoni, Andrea
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (08) : 1325 - 1327
  • [2] Response to “Immune-mediated cholangitis: is it always nivolumab’s fault?”
    Jumpei Kashima
    Yusuke Okuma
    Cancer Immunology, Immunotherapy, 2018, 67 : 1329 - 1330
  • [3] Response to "Immune-mediated cholangitis: is it always nivolumab's fault?"
    Kashima, Jumpei
    Okuma, Yusuke
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (08) : 1329 - 1330
  • [4] Nivolumab Immune-Mediated Pneumonitis
    Parthvi, Rukma
    Singh, Abhay
    AMERICAN JOURNAL OF THERAPEUTICS, 2020, 27 (06) : E617 - E618
  • [5] Nivolumab and immune-mediated colitis
    Walker, Heather
    Brennan, Paul
    Groome, Maximillian
    Walsh, Shaun
    Carey, Frank
    CLINICAL CASE REPORTS, 2019, 7 (04): : 644 - 647
  • [6] Immune-Mediated Colitis Induced by Intrathecal Nivolumab
    Panneerselvam, Kavea
    Wang, Yinghong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1449 - S1450
  • [7] Mast Cells in Immune-Mediated Cholangitis and Cholangiocarcinoma
    Gonzalez, Marisol I.
    Vannan, Danielle T.
    Eksteen, Bertus
    Flores-Sotelo, Iran
    Reyes, Jose Luis
    CELLS, 2022, 11 (03)
  • [8] Immune-Mediated Diseases in Primary Sclerosing Cholangitis
    Lamberts, Laetitia E.
    Janse, Marcel
    Haagsma, Elizabeth B.
    Van den Berg, Arie P.
    Weersma, Rinse K.
    GASTROENTEROLOGY, 2011, 140 (05) : S919 - S919
  • [9] Immune-mediated diseases in primary sclerosing cholangitis
    Lamberts, Laetitia E.
    Janse, Marcel
    Haagsma, Elizabeth B.
    van den Berg, Arie P.
    Weersma, Rinse K.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 (10) : 802 - 806
  • [10] Immune-Mediated Pneumonitis Due to Nivolumab: Is It Worth Using?
    Davis, R. M.
    Patel, P.
    Ikladios, O. I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
12345